{
    "clinical_study": {
        "@rank": "43488", 
        "acronym": "BASALT-2", 
        "arm_group": [
            {
                "arm_group_label": "Buparlisib + Carboplatin + Paclitaxel", 
                "arm_group_type": "Experimental", 
                "description": "Buparlisib + Carboplatin + Paclitaxel (100 patients)"
            }, 
            {
                "arm_group_label": "Placebo + Carboplatin + Paclitaxel", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo + Carboplatin + Paclitaxel (100 patients)"
            }
        ], 
        "brief_summary": {
            "textblock": "The Phase Ib part of the study aims to determine the maximum tolerated dose/recommended\n      Phase II dose (MTD/RP2D) of once daily buparlisib in combination with every-three-week\n      carboplatin and paclitaxel in patients with previously untreated metastatic squamous NSCLC.\n\n      The purpose of the Phase II portion of the study is to assess the treatment effect of adding\n      buparlisib versus buparlisib-matching placebo to every-three-week carboplatin and paclitaxel\n      on progression free survival (PFS) in patients with previously untreated metastatic squamous\n      NSCLC."
        }, 
        "brief_title": "Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Non-Small Cell Lunch Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient has histologically and/or cytologically confirmed diagnosis of squamous\n             NSCLC.  Diagnosis of mixed squamous with a squamous component will be acceptable for\n             enrollment.\n\n          -  Patient has archival or new tumor tissue for the  analysis of PI3K  biomarkers\n\n          -  Tumor is Stage IV at the time of signed informed consent (UICC/AJCC version 7)\n\n          -  Patient has measurable or non-measurable disease according to RECIST v1.1 criteria\n\n             \u2022 For the Phase II portion, the patient must have measurable disease according to\n             RECIST 1.1 criteria\n\n          -  Patient has an Eastern Cooperative Oncology Group (ECOG) performance status \u2264 1 that\n             the investigator believes is stable at the time of screening\n\n          -  Patient has adequate bone marrow and organ function\n\n        Exclusion Criteria:\n\n          -  Patient has received any prior systemic therapies for metastatic NSCLC. Study\n             treatment in this clinical trial must be the patient's first systemic treatment for\n             metastatic NSCLC. Patients are eligible if they received neo-adjuvant or adjuvant\n             systemic therapy followed by a disease-free interval exceeding 12 months.\n\n          -  Patient has symptomatic CNS metastases\n\n             \u2022 Patients with asymptomatic CNS metastases may participate in this trial. The\n             patient must have completed any prior local treatment for CNS metastases \u2265 28 days\n             prior to the start of study treatment (including radiotherapy and/or surgery, or \u226514\n             days for stereotactic radiosurgery).\n\n          -  Patient is currently receiving warfarin or other coumadin derived anticoagulant for\n             treatment, prophylaxis or otherwise. Therapy with heparin, low molecular weight\n             heparin (LMWH), or fondaparinux is allowed.\n\n          -  Patient is currently receiving treatment with drugs known to be strong inhibitors or\n             inducers of isoenzyme CYP3A. The patient must have discontinued strong inducers for\n             at least one week and must have discontinued strong inhibitors before the treatment\n             is initiated. Switching to a different medication prior to randomization is allowed.\n\n          -  Patient has a medically documented history of or active major depressive episode,\n             bipolar disorder (I or II), obsessive-compulsive disorder, schizophrenia, a history\n             of suicidal attempt or ideation, or homicidal ideation (e.g. risk of doing harm to\n             self or others) or patients with active severe personality disorders (defined\n             according to DSM- IV) are not eligible.  Note: for patients with psychotropic\n             treatments ongoing at baseline, the dose and the schedule should not be modified\n             within the previous 6 weeks prior to start of study drug\n\n          -  Patient has \u2265 CTCAE grade 3 anxiety\n\n          -  Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a\n             female after conception and until the termination of gestation, confirmed by a\n             positive hCG laboratory test (> 5 mIU/mL)\n\n          -  Patient who does not apply highly effective contraception during the study and\n             through the duration as defined below after the final dose of study treatment."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "220", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820325", 
            "org_study_id": "CBKM120D2204", 
            "secondary_id": "2012-005541-21"
        }, 
        "intervention": [
            {
                "arm_group_label": "Buparlisib + Carboplatin + Paclitaxel", 
                "intervention_name": "BKM120", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo + Carboplatin + Paclitaxel", 
                "description": "Placebo + Carboplatin + Paclitaxel", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Buparlisib + Carboplatin + Paclitaxel", 
                    "Placebo + Carboplatin + Paclitaxel"
                ], 
                "intervention_name": "Carboplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Buparlisib + Carboplatin + Paclitaxel", 
                    "Placebo + Carboplatin + Paclitaxel"
                ], 
                "intervention_name": "Paclitaxel", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Carboplatin", 
                "Paclitaxel"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Squamous non-small cell lung cancer, NSCLC, stage IV", 
        "lastchanged_date": "February 17, 2014", 
        "location": [
            {
                "contact": {
                    "email": "thesington@hogonc.com", 
                    "last_name": "Tia Hesington", 
                    "phone": "479-936-9900"
                }, 
                "facility": {
                    "address": {
                        "city": "Fayetteville", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72703"
                    }, 
                    "name": "Highlands Oncology Group SC-1"
                }, 
                "investigator": {
                    "last_name": "Eric S. Schaefer", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mejia_e@med.usc.edu", 
                    "last_name": "Eduardo Mejia", 
                    "phone": "323-865-3962"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "USC Norris Cancer Center LAC USC Medical Center"
                }, 
                "investigator": {
                    "last_name": "Barbara J. Gitlitz", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "roxanne.riggs@usoncology.com", 
                    "last_name": "Roxanne Riggs", 
                    "phone": "303-388-4876"
                }, 
                "facility": {
                    "address": {
                        "city": "Greenwood Village", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Rocky Mountain Cancer Centers Rocky Mountain Cancer Centers"
                }, 
                "investigator": {
                    "last_name": "Robert M. Jotte", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ree28@georgetown.edu", 
                    "last_name": "Rebecca Eberle", 
                    "phone": "202-687-5791"
                }, 
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Georgetown University/Lombardi Cancer Center Georgetown Univ. Medical Ctr."
                }, 
                "investigator": {
                    "last_name": "Giuseppe Giaccone", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jeff.jorski@moffitt.org", 
                    "last_name": "Jeff L. Jorski", 
                    "phone": "813-745-6895"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt"
                }, 
                "investigator": {
                    "last_name": "Jhanelle Gray", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "dawn_paulsen@rush.edu", 
                    "last_name": "Dawn Paulsen", 
                    "phone": "312-563-4593"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush University Medical Center Rush University"
                }, 
                "investigator": {
                    "last_name": "Mary J Fidler", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jcollins4@kumc.edu", 
                    "last_name": "Collins Julie", 
                    "phone": "+1 913 588 0545"
                }, 
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160"
                    }, 
                    "name": "University of Kansas Cancer Center Medical Pavilion"
                }, 
                "investigator": {
                    "last_name": "Chao Hui Huang", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sonia.martinath@reliantmedicalgroup.org", 
                    "last_name": "Sonia Martinath"
                }, 
                "facility": {
                    "address": {
                        "city": "Worchester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01608"
                    }, 
                    "name": "Reliant Medical Group Reliant Medical Group"
                }, 
                "investigator": {
                    "last_name": "Saleem Khanani", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sgajavel@montefiore.org", 
                    "last_name": "Srkantha Gajavelli", 
                    "phone": "718-405-8539"
                }, 
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10461"
                    }, 
                    "name": "Montefiore Medical Center SC BKM120 D2204 / D2205"
                }, 
                "investigator": {
                    "last_name": "Bilal Piperdi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "carl.skelly@roswellpark.org", 
                    "last_name": "Carol Skelly", 
                    "phone": "716-845-4886"
                }, 
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14263"
                    }, 
                    "name": "Roswell Park Cancer Institute Rosewell"
                }, 
                "investigator": {
                    "last_name": "Grace Dy", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fargo", 
                        "country": "United States", 
                        "state": "North Dakota", 
                        "zip": "58122"
                    }, 
                    "name": "Sanford Research/USD-Fargo"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "contact": {
                    "email": "denise.hill@usoncology.com", 
                    "last_name": "Denise M. Hill", 
                    "phone": "360-449-6522"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Northwest Cancer Specialists Compass Oncology -BKM"
                }, 
                "investigator": {
                    "last_name": "David A. Smith", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29425"
                    }, 
                    "name": "Medical University of South Carolina MUSC"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "contact": {
                    "email": "Tammy.A.Hein@Sanfordhealth.org", 
                    "last_name": "Tammy A Hein", 
                    "phone": "605-328-1376"
                }, 
                "facility": {
                    "address": {
                        "city": "Sioux Falls", 
                        "country": "United States", 
                        "state": "South Dakota", 
                        "zip": "57104"
                    }, 
                    "name": "Sanford Research Alick Building"
                }, 
                "investigator": {
                    "last_name": "Miroslaw Mazurczak", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ecox@biomed-research.com", 
                    "last_name": "Erica Cox", 
                    "phone": "865-934-2675"
                }, 
                "facility": {
                    "address": {
                        "city": "Knoxville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37909"
                    }, 
                    "name": "Tennessee Cancer Specialists Center for Biomedical Research"
                }, 
                "investigator": {
                    "last_name": "Russell F DeVore", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Emily.angarole@scresearch.net", 
                    "last_name": "Emily Angarole", 
                    "phone": "615-524-4086"
                }, 
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37203"
                    }, 
                    "name": "Sarah Cannon Research Institute BKM120D2204/BKM120D2205"
                }, 
                "investigator": {
                    "last_name": "David R. Spigel", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "barbara.j.broome@vanderbilt.edu", 
                    "last_name": "BJ Broome", 
                    "phone": "615-875-0060"
                }, 
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37203"
                    }, 
                    "name": "Vanderbilt Ingram Cancer Center SC (CTSR)"
                }, 
                "investigator": {
                    "last_name": "Leora Horn", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75246"
                    }, 
                    "name": "US Oncology Central Monitoring"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "contact": {
                    "email": "Ron.schoenfeldt@McKesson.com", 
                    "last_name": "Ron Schoenfeldt", 
                    "phone": "817-850-2000"
                }, 
                "facility": {
                    "address": {
                        "city": "Fort Worth", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76104"
                    }, 
                    "name": "Texas Oncology, P.A."
                }, 
                "investigator": {
                    "last_name": "Stephen L. Richey", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "susan.cooper@uth.tmc.edu", 
                    "last_name": "Susan Cooper", 
                    "phone": "832-325-7308"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "University of Texas Health Science Center Univ.TX Memorial Herman Cancer"
                }, 
                "investigator": {
                    "last_name": "Shan Guo", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ngarcia@stexresearch.com", 
                    "last_name": "Noe Garcia", 
                    "phone": "956-753-7839"
                }, 
                "facility": {
                    "address": {
                        "city": "Laredo", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78041"
                    }, 
                    "name": "Institute of Oncology Hematology"
                }, 
                "investigator": {
                    "last_name": "Eduardo Miranda", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "gabrielle.whalen@usocology.com", 
                    "last_name": "Gabrielle Whalen", 
                    "phone": "757-213-5658"
                }, 
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23502"
                    }, 
                    "name": "Virginia Oncology Associates BKM120D2205/BKM120D2204"
                }, 
                "investigator": {
                    "last_name": "Paul Conkling", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bah\u00eda Blanca", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "B8001HXM"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mar del Plata", 
                        "country": "Argentina", 
                        "state": "Buenos Aires", 
                        "zip": "B7600CTO"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rosario", 
                        "country": "Argentina", 
                        "state": "Santa Fe", 
                        "zip": "S2000KZE"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Capital Federal", 
                        "country": "Argentina", 
                        "zip": "1417"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clayton", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3168"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussel", 
                        "country": "Belgium", 
                        "zip": "1090"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liege", 
                        "country": "Belgium", 
                        "zip": "4000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Li\u00e8ge", 
                        "country": "Belgium", 
                        "zip": "4000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belo Horizonte", 
                        "country": "Brazil", 
                        "state": "MG", 
                        "zip": "30150-270"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Recife", 
                        "country": "Brazil", 
                        "state": "PE", 
                        "zip": "50070-550"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rio de Janiero", 
                        "country": "Brazil", 
                        "state": "RJ", 
                        "zip": "20231-050"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iju\u00ed", 
                        "country": "Brazil", 
                        "state": "RS", 
                        "zip": "98700-000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "RS", 
                        "zip": "90610-000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barretos", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "14784-400"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "S\u00e3o Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "01246-000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edmonton", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T6G 1Z2"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ottawa", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "KIH 7W9"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 1Z6"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brno", 
                        "country": "Czech Republic", 
                        "zip": "65653"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Prague 8", 
                        "country": "Czech Republic", 
                        "zip": "180 00"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Creteil", 
                        "country": "France", 
                        "zip": "94000"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif Cedex", 
                        "country": "France", 
                        "zip": "94805"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "89081"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1121"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gyor", 
                        "country": "Hungary", 
                        "zip": "9023"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nyiregyhaza", 
                        "country": "Hungary", 
                        "zip": "4400"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pecs", 
                        "country": "Hungary", 
                        "zip": "7624"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Veszpr\u00e9m", 
                        "country": "Hungary", 
                        "zip": "8200"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zalaegerszeg-P\u00f3zva", 
                        "country": "Hungary", 
                        "zip": "8900"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Catanzaro", 
                        "country": "Italy", 
                        "state": "CZ", 
                        "zip": "88100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy", 
                        "state": "GE", 
                        "zip": "16132"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monza", 
                        "country": "Italy", 
                        "state": "MB", 
                        "zip": "20900"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20141"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20133"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rozzano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20089"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy", 
                        "state": "PD", 
                        "zip": "35100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Napoli", 
                        "country": "Italy", 
                        "zip": "80131"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nizhniy Novgorod", 
                        "country": "Russian Federation", 
                        "state": "Russia"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chelyabinsk", 
                        "country": "Russian Federation", 
                        "zip": "454087"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sankt-Peterburg", 
                        "country": "Russian Federation", 
                        "zip": "197022"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "197758"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bloemfontein", 
                        "country": "South Africa", 
                        "zip": "9300"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pretoria", 
                        "country": "South Africa", 
                        "zip": "0027"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pretoria", 
                        "country": "South Africa", 
                        "zip": "0002"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08035"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kuei-Shan Chiang", 
                        "country": "Taiwan", 
                        "state": "Taoyuan/ Taiwan ROC", 
                        "zip": "33305"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Niaosong Township", 
                        "country": "Taiwan", 
                        "zip": "83301"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taichung", 
                        "country": "Taiwan", 
                        "zip": "40447"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gaziantep", 
                        "country": "Turkey", 
                        "zip": "27070"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey", 
                        "zip": "34303"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Izmir", 
                        "country": "Turkey", 
                        "zip": "35040"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sihhiye/Ankara", 
                        "country": "Turkey", 
                        "zip": "06100"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom", 
                        "zip": "B9 5SS"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leicester", 
                        "country": "United Kingdom", 
                        "zip": "LE1 5WW"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wirral", 
                        "country": "United Kingdom", 
                        "zip": "CH63 3JY"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Suspended"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Australia", 
                "Belgium", 
                "Brazil", 
                "Canada", 
                "Czech Republic", 
                "France", 
                "Germany", 
                "Hungary", 
                "Italy", 
                "Russian Federation", 
                "South Africa", 
                "Spain", 
                "Taiwan", 
                "Turkey", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Dose-finding Phase Ib Study Followed by a Randomized, Double-blind Phase II Study of Carboplatin and Paclitaxel With or Without Buparlisib in Patients With Previously Untreated Metastatic Non-small Cell Lung Cancer (NSCLC) of Squamous Histology", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "1-888-669-6682"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone_ext": "+41613241111"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica", 
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "Brazil: National Health Surveillance Agency", 
                "Canada: Health Canada", 
                "China: Food and Drug Administration", 
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Hungary: National Institute of Pharmacy", 
                "Italy: National Institute of Health", 
                "Japan: Pharmaceuticals and Medical Devices Agency", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
                "Spain: Spanish Agency of Medicines", 
                "Taiwan: Department of Health", 
                "Turkey: Ministry of Health", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Determine the MTD and/or RP2D of daily buparlisib in combination with paclitaxel and carboplatin in patients with advanced or metastatic squamous NSCLC.", 
                "measure": "Number of Total Dose-limiting Toxicity (DLT) During Dose Escalation to Determine Maximum Tolerated Dose (MTD)", 
                "safety_issue": "Yes", 
                "time_frame": "Cycle 1 (21 days)"
            }, 
            {
                "description": "Progression-free survival is defined as the time from randomization to the date of the first documented progression or death from any cause. The Kaplan-Meier estimate of the PFS survival function was contructed.", 
                "measure": "Progression Free Survival (PFS) as measured using RECIST 1.1", 
                "safety_issue": "No", 
                "time_frame": "Randomization, every 6 weeks to the date of first document progression for up to 3 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820325"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Overall response is the number of participants who had a complete response (CR) or a partial response (PR) based on local investigator's assessment of RECIST criteria. Per RECIST: CR, all detectable tumor has disappeared; PR, a >=30% decrease in the sum of the longest dimensions of the target lesions (TLs) taking as a reference the baseline sum, no worsening of non-TLs, and no new lesions; Progressive disease (PD), a >=20% increase in TLs, clearly worsening of non-TLs, or emergence of new lesions; Stable Disease (SD), small changes that do not meet previously given criteria.", 
                "measure": "Number of Participants With Best Overall Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST)", 
                "safety_issue": "No", 
                "time_frame": "Every 6 weeks from randomization until first documented progression for up to 3 years"
            }, 
            {
                "description": "Overall survival (OS) time was measured from the start of study drug to the date of death due to any cause. If a patient was not known to have died, survival was censored at the date of last contact. Data was collected post treatment every 6 weeks until approximately 75% of patients have reached the survival endpoint (Phase I + Phase II).", 
                "measure": "Overall Survival Time", 
                "safety_issue": "No", 
                "time_frame": "Every 6 weeks from randomization until first documented progression for up to 3 years"
            }, 
            {
                "description": "Time to overall response (TTR) is defined as the time from the date of first drug intake in Phase Ib and from the date of randomization in Phase II to the date of first documented response. TTR will primarily be listed.", 
                "measure": "Time to overall response", 
                "safety_issue": "No", 
                "time_frame": "Every 6 weeks from randomization until first documented progression for up to 3 years"
            }, 
            {
                "description": "Assessments consisted of recording all AEs and serious adverse events (SAEs), the regular monitoring of hematology, blood chemistry, vital signs, physical condition and body weight.", 
                "measure": "The Overall Safety and Tolerability of buparlisib (BKM120)", 
                "safety_issue": "Yes", 
                "time_frame": "Screening, Until 30 days after last dose"
            }, 
            {
                "description": "Quality of life (QoL) is evaluated using EORTC QLQ-C30 and QLQ-LC-13 scale. QLQ-L30 is composed of 30 items, whose responses range from 0 to 4. The QLQ-LC13 is used in conjucntion with the QLQ-C30 and provides information on an additional 13 items specifically relating to lung cancer. It incorporates one multi-item scale to assess dyspnea and a series of single-item scale to assess pain, coughing, sore mouth, dysphagia, peripheral neuropathy, alopecia, and haemoptysis. All the multi-item scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level. Thus a high score for a functional scale represents a high / healthy level of functioning, a high score for the global health status / QoL represents a high QoL, but a high score for a symptom scale / item represents a high level of symptomatology / problems.", 
                "measure": "Change From Baseline in Quality of Life Measured by the Functional Assessment of EORTC QLQ- C-30 and lung cancer module (QLQ-LC-13)", 
                "safety_issue": "Yes", 
                "time_frame": "Screening, Every 6 weeks until disease progression for up to 3 years"
            }, 
            {
                "description": "Time to definitive 10% deterioration in the global health status / QoL, physical functioning, emotional functioning, social functioning, and lung cancer symptoms scales will be assessed in the two treatment arms.", 
                "measure": "Time to deterioration by the Functional Assessment of EORTC QLQ- C-30 and lung cancer module (QLQ-LC-13)", 
                "safety_issue": "Yes", 
                "time_frame": "Screening, Every 6 weeks until disease progression for up to 3 years"
            }, 
            {
                "description": "Pharmacokinetics of buparlisib will be investigated in order to investigate any unexpected impact of carboplatin and paclitaxel therapy on the pharmacokinetics of buparlisib. For this purpose, plasma samples will be collected during phase II of the trial. In one set of the population (N=40) samples will be collected according to a sparse sampling strategy over the entire course of the treatment, to allow a proper estimate of the pharmacokinetic parameters.  In addition, trough samples should be collected, for the whole population, for measurement of buparlisib/placebo. These additional samples will allow investigating potential PK/PD relationships for various therapeutic or adverse outcome in the whole study population.", 
                "measure": "Buparlisib concentrations", 
                "safety_issue": "No", 
                "time_frame": "Cycle 1 day 8 and 15, Cycle 2 day 1, Cycle 7-Cycle n, day 1"
            }, 
            {
                "description": "Duration of overall response (DR) is defined as the elapsed time between the date of first documented response and the following date of event defined as the first documented progression or death due to underlying cancer. DR will primarily be listed. DR may be described using Kaplan-Meier curves and any related statistics if relevant and will be presented by treatment group in phase II. These analyses will be performed on the responder subset, i.e. patients with a confirmed complete response (CR) or partial response (PR).", 
                "measure": "Duration of overall response", 
                "safety_issue": "No", 
                "time_frame": "Every 6 weeks from randomization until first documented progression for up to 3 years"
            }, 
            {
                "description": "Buparlisib concentrations and model-based PK derived parameters", 
                "measure": "Characterize the PK of buparlisib under alternative dosing regimen when combined with paclitaxel and carboplatin in the target population", 
                "safety_issue": "No", 
                "time_frame": "cycle 1 to 6 in Phase Ib portion"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}